Clinicopathologic Implications of EpCAM and Sox2 Expression in Breast Cancer

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2013.09.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correlation Between SOX2 and Mutant IDH1 Protein Expression in Astrocytomas and Their Clinicopathologic Significance

The Medical Journal of Cairo University
2018English

Increased EpCAM Expression in Malignant Insulinoma: Potential Clinical Implications

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2010English

High Expression of EpCAM and Sox2 Is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma

Scientific Reports
Multidisciplinary
2018English

Prognostic Significance of EpCAM Expression in Human Esophageal Cancer

International Journal of Oncology
Cancer ResearchOncology
2007English

Higher Expression of EpCAM Is Associated With Poor Clinical and Pathological Responses in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Pathology International
MedicineForensic MedicinePathology
2016English

A Clinicopathologic Study of Breast Cancer Patients During Pregnancy

Kitakanto Medical Journal
Medicine
2006English

Analysis of the Specificity and Selectivity of Anti-EpCAM Antibodies in Breast Cancer Cell Lines

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2012English

Immunohistochemical Expression of Nanog and Its Relation With Clinicopathologic Characteristics in Breast Ductal Carcinoma

Iranian Biomedical Journal
BiochemistryClinical BiochemistryGeneticsMolecular Biology
2019English

Expression of EpCAM in Uveal Melanoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy